Harnessing post-translational modifications for a tuberculosis booster vaccine

FHS
June 19, 2024
4:26 pm

Tuberculosis is still one of the deadliest infectious diseases, causing over one million deaths each year worldwide.

To counter mpox, vaccine maker could ramp up by another 8 million doses next year

When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the

August 16, 2024

Dementia Diagnoses in Primary Care

Negotiations are underway in medical literature and clinics as to who should diagnose dementia, in light of new anti-amyloid monoclonal antibodies — lecanemab (Leqembi) and

July 6, 2024

Convictions Over Bleach ‘Cure’; FDA OKs Anthrax Vaccine; WHO Donations Draw Scrutiny

Note that some links may require subscriptions. A Florida father and his three sons were convicted of selling a toxic bleach solution as a “miracle”

July 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.